Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-02

Clinical Trial Update: Carotegrast Methyl in Ulcerative Colitis [Phase 4]

View source ↗

Summary

Phase 4 study evaluating Carotegrast Methyl for Ulcerative Colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carotegrast Methyl (carotegrast methyl)

Snippet

Sponsor: Takayuki Yamamoto | Conditions: Ulcerative Colitis | Phase 4 | Status: COMPLETED